Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Pilavapadin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lexicon Supports Ph III Go Decision for Non-Opioid Pain Med
    Lexicon Supports Ph III Go Decision for Non-Opioid Pain Med

    18 Sep 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/lexicon-backs-phase-iii-go-decision-for-non-opioid-pain-med-with-post-hoc-analysis

    BIOSPACE
    18 Sep 2025
    Share Share
    Pilavapadin Shows Significant Pain Relief in Adults
    Pilavapadin Shows Significant Pain Relief in Adults

    17 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/17/3151499/0/en/Pilavapadin-Provides-Meaningful-Pain-Reduction-in-Adults-with-Diabetic-Peripheral-Neuropathic-Pain-DPNP-in-Data-Presented-at-the-European-Association-for-the-Study-of-Diabetes-EASD.html

    GLOBENEWSWIRE
    17 Sep 2025
    Share Share
    Lexicon Pharma to Share More Pilavapadin Clinical Data at Meeting
    Lexicon Pharma to Share More Pilavapadin Clinical Data at Meeting

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148532/0/en/Lexicon-Pharmaceuticals-to-Present-Additional-Clinical-Data-on-Pilavapadin-at-Three-Upcoming-Medical-Meetings.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    Lexicon Presents Diabetic Neuropathic Pain at PAINWeek
    Lexicon Presents Diabetic Neuropathic Pain at PAINWeek

    03 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/03/3143605/0/en/Lexicon-Pharmaceuticals-Announces-Presentation-of-Diabetic-Peripheral-Neuropathic-Pain-Patient-Insights-at-PAINWeek-2025.html

    GLOBENEWSWIRE
    03 Sep 2025
    Share Share
    Lexicon Pharma To Release Ph 2b Results For Diabetic Neuropathic Pain
    Lexicon Pharma To Release Ph 2b Results For Diabetic Neuropathic Pain

    03 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/02/3035198/0/en/Lexicon-Pharmaceuticals-to-Announce-Topline-Results-from-Phase-2b-PROGRESS-Study-Evaluating-Pilavapadin-LX9211-in-Adults-with-Diabetic-Peripheral-Neuropathic-Pain.html

    GLOBENEWSWIRE
    03 Mar 2025
    Share Share
    Lexicon Ph2b Study Shows Pilavapadin Benefit In Diabetic Pain
    Lexicon Ph2b Study Shows Pilavapadin Benefit In Diabetic Pain

    03 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/03/3035469/0/en/Lexicon-Pharmaceuticals-Announces-Topline-Results-from-Phase-2b-PROGRESS-Study-Evaluating-Pilavapadin-LX9211-in-Adults-with-Diabetic-Peripheral-Neuropathic-Pain.html

    GLOBENEWSWIRE
    03 Mar 2025
    Share Share